Wisconsin Association of Hematology and Oncology

Latest Content

Please check back later for more content.

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma

Alert-Based ePRO Monitoring Reduces Fatigue in Metastatic Breast Cancer

FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma

ASTRO Issues Updated Clinical Practice Guideline on RT for Pancreatic Cancer

AMH Testing Predicts Chemotherapy Benefit in RxPONDER Breast Cancer